ADENTRA (ADEN) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
27 Apr, 2026Executive summary
Achieved stable financial results in 2024 despite industry headwinds, with full-year sales at $2.18 billion, down 2.5% year-over-year, and Q4 sales up 3.1% to $530.8 million.
Gross margin improved to 21.7% for both the year and Q4, up 90 bps year-over-year.
Net income for 2024 increased 28.9% to $46.5 million, with basic EPS rising to $1.95 from $1.61 in 2023.
Completed $130 million acquisition of Woolf Distributing, expanding geographic reach and product portfolio, accretive to adjusted EPS from day one.
Maintained annual dividend increases for 12 consecutive years and completed 16 acquisitions in 15 years.
Financial highlights
Q4 sales rose by $16 million to $530.8 million, driven by Woolf acquisition; organic sales declined by 3.4%.
US operations generated $2.01 billion in sales, down 6% year-over-year, mainly due to product price deflation and lower volumes.
Canadian sales rose 3% to C$235.9 million, with Q4 sales up 7.8% year-over-year, driven by higher volumes but offset by lower prices.
Adjusted EBITDA for 2024 was $184.3 million, nearly flat year-over-year; Q4 Adjusted EBITDA was $42.2 million, down 5.1%.
Strong cash flow from operations at $142.8 million for the year, with Q4 operating cash flow at $34.9 million and an 82% EBITDA-to-cash conversion rate.
Outlook and guidance
Organic sales down 6% year-over-year in the first two months of Q1 2025, mainly due to lower volumes and weather impacts.
Market headwinds expected to persist in 2025, including high US mortgage rates, constrained housing supply, and potential tariff impacts.
Pricing trends stabilizing after 2024 declines; some product price inflation expected due to tariffs, with a pricing pass-through model in place.
Long-term housing fundamentals remain strong, with historic undersupply and favorable demographics.
Latest events from ADENTRA
- Margin and EPS growth, M&A, and digital initiatives drive stable outlook and long-term growth.ADEN
Q2 202427 Apr 2026 - Sales up 1.8% to $568.8M, net income up 28.7%, gross margin 21.3%, and dividend increased.ADEN
Q3 202427 Apr 2026 - Sales up 1.4% from acquisition, but organic sales and earnings declined amid macro headwinds.ADEN
Q1 202527 Apr 2026 - Q3 sales rose 4.1% to $592.1M, with margin gains and strong cash flow despite market headwinds.ADEN
Q3 202527 Apr 2026 - Sustained growth, strategic acquisitions, and operational excellence drive long-term value creation.ADEN
Investor presentation16 Mar 2026 - Strong growth, disciplined M&A, and operational excellence drive double-digit returns.ADEN
Investor presentation16 Mar 2026 - 2025 sales and net income grew, with robust cash flow, higher margins, and increased dividends.ADEN
Q4 202512 Mar 2026 - Q2 sales up 8.7% to $597.1M, with margin growth and strong cash flow despite trade risks.ADEN
Q2 202523 Nov 2025 - Sustained growth, strong M&A, and operational excellence drive double-digit shareholder returns.ADEN
Investor Presentation7 Aug 2025